background image

Paid Clinical Trials Fort Wayne

Discover 115 paid clinical trials in Fort Wayne, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for
Breast Cancer
Location: Fort Wayne IN, Lansing MI, Cincinnati OH, Chicago IL,
Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting

Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

Location: Fort Wayne IN, Lansing MI, Farmington Hills MI,
Sponsor: Bayer

Sex: All

Age: 0 - 70+

Code: NCT04142437

Recruiting

A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Fort Wayne IN, Cincinnati OH, Hinsdale IL, Hamilton,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT05650632

Phase1, Recruiting

A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-treatment Period.

for
Chronic Lymphocytic Leukemia
Location: Fort Wayne IN, Columbus OH, Cincinnati OH, Milwaukee WI,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT06524375

Phase2, Recruiting

TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

for
Cancer
Location: Fort Wayne IN, Goshen IN, Maumee OH, Hinsdale IL,
Sponsor: Tempus AI

Sex: All

Age: 18 - 70+

Code: NCT06207032

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

for
Non Small Cell Lung Cancer
Location: Fort Wayne IN, Lafayette IN, Edgewood KY, St Louis MO,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312137

Phase3, Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Fort Wayne IN, Grand Rapids MI, Edgewood KY, Madison WI,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase3, Recruiting

BostonGene and Exigent Genomic INsight Study

for
Breast Cancer, Non-small Cell Lung Cancer, Melanoma, Sarcoma
Location: Fort Wayne IN, Rogers AR, Tulsa OK, Houston TX,
Sponsor: BostonGene

Sex: All

Age: 18+

Code: NCT06272864

Recruiting

Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling

for
HER2-negative Breast Cancer
Location: Fort Wayne IN, Dayton OH, Ann Arbor MI, Marion OH,
Sponsor: NSABP Foundation Inc

Sex: Female

Age: 18+

Code: NCT03412643

Phase2, Recruiting

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab

for
Non-Small Cell Lung Cancer,
Location: Fort Wayne IN, Indianapolis IN, Grand Rapids MI,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT05005403

Phase1, Recruiting